166 related articles for article (PubMed ID: 1848340)
1. The effects of delta 9-tetrahydrocannabinol and other cannabinoids on cAMP accumulation in synaptosomes.
Little PJ; Martin BR
Life Sci; 1991; 48(12):1133-41. PubMed ID: 1848340
[TBL] [Abstract][Full Text] [Related]
2. Suppression of the humoral immune response by cannabinoids is partially mediated through inhibition of adenylate cyclase by a pertussis toxin-sensitive G-protein coupled mechanism.
Kaminski NE; Koh WS; Yang KH; Lee M; Kessler FK
Biochem Pharmacol; 1994 Nov; 48(10):1899-908. PubMed ID: 7986201
[TBL] [Abstract][Full Text] [Related]
3. Modulation of free intracellular calcium and cAMP by morphine and cannabinoids, alone and in combination in mouse brain and spinal cord synaptosomes.
Pugh G; Welch SP; Bass PP
Pharmacol Biochem Behav; 1994 Dec; 49(4):1093-100. PubMed ID: 7886081
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological profile of a series of bicyclic cannabinoid analogs: classification as cannabimimetic agents.
Compton DR; Johnson MR; Melvin LS; Martin BR
J Pharmacol Exp Ther; 1992 Jan; 260(1):201-9. PubMed ID: 1309872
[TBL] [Abstract][Full Text] [Related]
5. Specific inhibition of FSH-stimulated cAMP accumulation by delta 9-tetrahydrocannabinol in cultures of rat Sertoli cells.
Heindel JJ; Keith WB
Toxicol Appl Pharmacol; 1989 Oct; 101(1):124-34. PubMed ID: 2552614
[TBL] [Abstract][Full Text] [Related]
6. Possible role of prostaglandins in the effects of the cannabinoids on adenylate cyclase activity.
Hillard CJ; Bloom AS
Eur J Pharmacol; 1983 Jul; 91(1):21-7. PubMed ID: 6311573
[TBL] [Abstract][Full Text] [Related]
7. Effects of delta 9-tetrahydrocannabinol on glucagon receptor coupling to adenylate cyclase in rat liver plasma membranes.
Hillard CJ; Bloom AS; Houslay MD
Biochem Pharmacol; 1986 Aug; 35(16):2797-803. PubMed ID: 3017362
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoids of diverse structure inhibit two DOI-induced 5-HT(2A) receptor-mediated behaviors in mice.
Darmani NA
Pharmacol Biochem Behav; 2001 Feb; 68(2):311-7. PubMed ID: 11267636
[TBL] [Abstract][Full Text] [Related]
9. Modulation of cannabinoid-induced antinociception after intracerebroventricular versus intrathecal administration to mice: possible mechanisms for interaction with morphine.
Welch SP; Thomas C; Patrick GS
J Pharmacol Exp Ther; 1995 Jan; 272(1):310-21. PubMed ID: 7815346
[TBL] [Abstract][Full Text] [Related]
10. Characterization of anandamide- and fluoroanandamide-induced antinociception and cross-tolerance to delta 9-THC after intrathecal administration to mice: blockade of delta 9-THC-induced antinociception.
Welch SP; Dunlow LD; Patrick GS; Razdan RK
J Pharmacol Exp Ther; 1995 Jun; 273(3):1235-44. PubMed ID: 7791096
[TBL] [Abstract][Full Text] [Related]
11. Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs.
Martin BR; Compton DR; Thomas BF; Prescott WR; Little PJ; Razdan RK; Johnson MR; Melvin LS; Mechoulam R; Ward SJ
Pharmacol Biochem Behav; 1991 Nov; 40(3):471-8. PubMed ID: 1666911
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of adenylate cyclase by delta 9-tetrahydrocannabinol in mouse spleen cells: a potential mechanism for cannabinoid-mediated immunosuppression.
Schatz AR; Kessler FK; Kaminski NE
Life Sci; 1992; 51(6):PL25-30. PubMed ID: 1321935
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid effects on adenylate cyclase and phosphodiesterase activities of mouse brain.
Dolby TW; Kleinsmith LJ
Can J Physiol Pharmacol; 1977 Aug; 55(4):934-42. PubMed ID: 198079
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of cAMP involvement in cannabinoid-induced antinociception.
Cook SA; Welch SP; Lichtman AH; Martin BR
Life Sci; 1995; 56(23-24):2049-56. PubMed ID: 7776831
[TBL] [Abstract][Full Text] [Related]
15. Effects of cannabinoids on catecholamine uptake and release in hypothalamic and striatal synaptosomes.
Poddar MK; Dewey WL
J Pharmacol Exp Ther; 1980 Jul; 214(1):63-7. PubMed ID: 7391971
[TBL] [Abstract][Full Text] [Related]
16. Stereochemical effects of 11-OH-delta 8-tetrahydrocannabinol-dimethylheptyl to inhibit adenylate cyclase and bind to the cannabinoid receptor.
Howlett AC; Champion TM; Wilken GH; Mechoulam R
Neuropharmacology; 1990 Feb; 29(2):161-5. PubMed ID: 2158635
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of protein kinase A and cyclic AMP response element (CRE)-specific transcription factor binding by delta9-tetrahydrocannabinol (delta9-THC): a putative mechanism of cannabinoid-induced immune modulation.
Koh WS; Crawford RB; Kaminski NE
Biochem Pharmacol; 1997 May; 53(10):1477-84. PubMed ID: 9260875
[TBL] [Abstract][Full Text] [Related]
18. The preimplantation mouse embryo is a target for cannabinoid ligand-receptor signaling.
Paria BC; Das SK; Dey SK
Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9460-4. PubMed ID: 7568154
[TBL] [Abstract][Full Text] [Related]
19. Effects of cannabinoids on the activities of mouse brain lipases.
Hunter SA; Burstein S; Renzulli L
Neurochem Res; 1986 Sep; 11(9):1273-88. PubMed ID: 3024047
[TBL] [Abstract][Full Text] [Related]
20. In vitro effects of cannabinoids on follicular function in the rat.
Reich R; Laufer N; Lewysohn O; Cordova T; Ayalon D; Tsafriri A
Biol Reprod; 1982 Aug; 27(1):223-31. PubMed ID: 6288130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
